[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

X S Zhang; Bin Liu; Xin Du; Y L Zhang; Na Xu; Xi Liu; W M Li; Hai Lin; Rachel Liang; Ching‐Yu Chen; Jian Huang; Yuchao Yang; Huanling Zhu; Li Pan; Xiaoyong Wang; G H Li; Z G Liu; Y Q Zhang; Zhongfan Liu; Jianda Hu; C S Liu; Fei Li; Wei Yang; Meng Li; Y.Q. Han; Lie Lin; Zheng Zhao; Chenge Tu; Chuanru Zheng; Yaling Bai; Z P Zhou; S N Chen; Huiying Qiu; Lili Yang; Xiuli Sun; Hao Sun; Liang Zhou; Zhong Liu; Dingyuan Wang; Jianxin Guo; L P Pang; Qingze Zeng; X H Suo; W H Zhang; Yingjie Zheng; Jiang Qian

doi:10.3760/cma.j.cn121090-20231108-00255

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

To retrospectively analyze the treatment status of tyrosine kinase inhibitors (TKI) in newly diagnosed patients with chronic myeloid leukemia (CML) in China.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e74210b6db6435876bbbef https://doi.org/10.3760/cma.j.cn121090-20231108-00255

View at Publisher

Ask AI

Bookmark

Share

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

Ask about this paper

Abstract

Discussion

Cite This Study

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading